作者
S. Moquin,Oliver Simon,Ratna Karuna,Suresh B. Lakshminarayana,Fumiaki Yokokawa,Feng Wang,Chandrassegar Saravanan,Jin Zhang,Craig W. Day,Katherine Chan,Qingyin Wang,Siyan Lu,Hansong Dong,Kah Fei Wan,Siew Pheng Lim,Wei Liu,Cheah Chen Seh,Yen-Liang Chen,Haoying Xu,David T. Barkan,Cyrille Kounde,Wei Lin Sandra Sim,Gang Wang,Hui-Quan Yeo,Bin Zou,Wai Ling Chan,Mei Ding,Jae-Geun Song,Min Li,Colin Osborne,Francesca Blasco,Christopher R. Sarko,David Beer,Ghislain M. C. Bonamy,Vito G. Sasseville,Pei–Yong Shi,Thierry T. Diagana,Bryan K. S. Yeung,Feng Gu
摘要
NITD-688, a pan-serotype dengue virus inhibitor, is effective in mice and is well tolerated with favorable pharmacokinetics in animal models.